Akili’s ADHD digital therapy approved in Europe
The European Commission has granted a CE mark for the game called EndeavorRx, allowing the product to be marketed in Europe although it is not yet available. Akili’s focus in the near term is a US launch following FDA approval earlier this month, but said it is “exploring expansion opportunities” in Europe.
Other Articles in this Edition
Major Depression Later in Life May Be Linked to ADHD Genetic Liability
Challenges With Diagnosing ADHD
Study finds link between hoarding and ADHD
A shorter IQ test for children with special needs
Can Playing Video Games Improve ADHD?